Pfizer/Hoechst Inhaled Insulin Phase III Trials To Begin In Spring
Executive Summary
Phase III trials of Pfizer's inhaled insulin product will begin in the spring of 1999, Pfizer Central Research President George Milne told a meeting with securities analysts in New York City Nov. 6.